New York AG Tish James sued former Emergent BioSolutions CEO over alleged insider trading around the COVID vaccine.

Robert Kramer, former CEO of Emergent BioSolutions, allegedly earned more than $10.1 million by executing trades with ...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article ...

New York's attorney general has filed an insider trading lawsuit against former Emergent BioSolutions CEO Robert Kramer, ...

Letitia James accused Robert Kramer of selling his shares in Emergent before disclosing contamination issues in its ...

Robert G. Kramer sold nearly 90,000 shares of his stock in Emergent BioSolutions, knowing that large quantities of vaccine ...

Emergent BioSolutions (NYSE:EBS) said the U.S. Food and Drug Administration has approved a supplemental New Drug Application ...

A former chief executive of Emergent BioSolutions was charged on Thursday with insider trading by New York Attorney General ...

New York Attorney General sued the former CEO of Emergent BioSolutions, Robert G. Kramer, for insider trading.

Emergent BioSolutions Inc. (NYSE:EBS) is one of the Best Performing Affordable Stocks Under $40. On January 8, Emergent ...

A former biotech CEO pocketed more than $10 million by selling company stock after learning of serious COVID-19 vaccine ...

Narcan Nasal Spray is an opioid antagonist that reverses the effects of opioids, including respiratory depression, sedation, and hypotension.